FR2439181A1 - Peptides apparentes a la somatostatine et leur utilisation therapeutique - Google Patents

Peptides apparentes a la somatostatine et leur utilisation therapeutique

Info

Publication number
FR2439181A1
FR2439181A1 FR7924443A FR7924443A FR2439181A1 FR 2439181 A1 FR2439181 A1 FR 2439181A1 FR 7924443 A FR7924443 A FR 7924443A FR 7924443 A FR7924443 A FR 7924443A FR 2439181 A1 FR2439181 A1 FR 2439181A1
Authority
FR
France
Prior art keywords
somatostatin
therapeutic use
related peptides
bopi
secretion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7924443A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of FR2439181A1 publication Critical patent/FR2439181A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

TETRADECAPEPTIDE CYCLIQUE DE FORMULE: (CF DESSIN DANS BOPI) DANS LAQUELLE: (CF DESSIN DANS BOPI) OU UN DE SES SELS D'ADDITION D'ACIDE PHARMACEUTIQUEMENT ACCEPTABLES NON TOXIQUES. CES COMPOSES ONT UNE ACTIVITE PHARMACOLOGIQUE, EN PARTICULIER COMME AGENT D'INHIBITION DE LA SECRETION DE L'HORMONE DE CROISSANCE.
FR7924443A 1978-10-02 1979-10-01 Peptides apparentes a la somatostatine et leur utilisation therapeutique Withdrawn FR2439181A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/948,117 US4202802A (en) 1978-10-02 1978-10-02 Peptides related to somatostatin

Publications (1)

Publication Number Publication Date
FR2439181A1 true FR2439181A1 (fr) 1980-05-16

Family

ID=25487300

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7924443A Withdrawn FR2439181A1 (fr) 1978-10-02 1979-10-01 Peptides apparentes a la somatostatine et leur utilisation therapeutique
FR8007779A Pending FR2453138A1 (fr) 1978-10-02 1980-04-04 Tetradecapeptides lineaires, intermediaires de synthese d'homologues de somatostatine

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR8007779A Pending FR2453138A1 (fr) 1978-10-02 1980-04-04 Tetradecapeptides lineaires, intermediaires de synthese d'homologues de somatostatine

Country Status (9)

Country Link
US (1) US4202802A (fr)
EP (1) EP0011366A3 (fr)
JP (1) JPS5549344A (fr)
BE (1) BE879107A (fr)
CA (1) CA1129846A (fr)
FR (2) FR2439181A1 (fr)
GB (1) GB2030572B (fr)
IL (1) IL58337A0 (fr)
LU (1) LU81733A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2458539A1 (fr) * 1979-06-11 1981-01-02 Lilly Co Eli Peptides apparentes a la somatostatine, leur preparation et leur utilisation therapeutique

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4369179A (en) * 1979-12-14 1983-01-18 Ciba-Geigy Corporation Acylpeptides
US4585740A (en) * 1983-05-03 1986-04-29 The Whittier Institute For Diabetes And Endocrinology Prolactin immunoassay using synthetic peptide

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362121A1 (fr) * 1976-03-08 1978-03-17 Lilly Co Eli Homologues de somatostatine, et intermediaires de preparation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904594A (en) * 1973-07-02 1975-09-09 Salk Inst For Biological Studi Somatostatin and acylated des-(ala' 1', gly' 2') derivatives thereof
DE2416048A1 (de) * 1974-04-03 1975-10-30 Hoechst Ag Neue peptide mit biologischer wirkung
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides
US4100117A (en) * 1977-04-21 1978-07-11 Eli Lilly And Company Somatostatin analogs and intermediates thereto

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2362121A1 (fr) * 1976-03-08 1978-03-17 Lilly Co Eli Homologues de somatostatine, et intermediaires de preparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2458539A1 (fr) * 1979-06-11 1981-01-02 Lilly Co Eli Peptides apparentes a la somatostatine, leur preparation et leur utilisation therapeutique

Also Published As

Publication number Publication date
GB2030572A (en) 1980-04-10
CA1129846A (fr) 1982-08-17
BE879107A (fr) 1980-04-01
EP0011366A2 (fr) 1980-05-28
JPS5549344A (en) 1980-04-09
EP0011366A3 (fr) 1982-02-10
US4202802A (en) 1980-05-13
LU81733A1 (fr) 1980-01-24
GB2030572B (en) 1982-10-13
FR2453138A1 (fr) 1980-10-31
IL58337A0 (en) 1979-12-30

Similar Documents

Publication Publication Date Title
NO813138L (no) Fremgangsmaate for fremstilling av fysiologisk aktive amidinderivater.
DE69625906T2 (de) Dinukleotide zur verwendung in der behandlung von lungenkrankheiten
GB8712073D0 (en) Medicament
MY100947A (en) External pharmaceutical composition.
FI842760A0 (fi) Menetelmä terapeuttisesti aktiivisten imidatsoliumyhdisteiden valmistamiseksi
JPS53119844A (en) Optically active amino acid-mandelic acid complexes and theire preparation
ES472847A1 (es) Procedimiento para la preparacion de la 2-bromoergosina y sus sales acidas de adicion
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
NO163957C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive karbapenemforbindelser.
FI800779A (fi) Peptider med ubikitin liknande aktivitet
ES455691A1 (es) Procedimiento para la produccion de derivados de piperacina.
FR2439181A1 (fr) Peptides apparentes a la somatostatine et leur utilisation therapeutique
FR2413370A1 (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
FR2392966A1 (fr) Nouveaux acides uree-bis(naphtalene-sulfoniques et naphtalene-carboxyliques), leurs sels pharmaceutiquement acceptables, et leur utilisation therapeutique
ES8308317A1 (es) Procedimiento de preparacion de nuevos derivados de 2-fenilmorfolina.
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana
IE790237L (en) Benzimidazol-2-ones.
JPS53124267A (en) 1-alkoxyacyl-3-(3,5-dihalogenophenyl)hydantoin derivatives, their preparation and bactericides for agricultural and horticultural uses containing the same as active agent
KR900016130A (ko) 2-피리딜메틸티오 유도체 및 궤양 치료제
FR2397401A1 (fr) Esters carboxymethyliques d'acides mercaptopropanoiques, et leur utilisation therapeutique
JPS5430165A (en) 2-allylamino-5-phenyloxazoles and their pharmaceutically acceptable aicd salts
JPS5675427A (en) Antiarteriosclerotic agent containing procainamide hydrochloride
JPS5430167A (en) 4-aminomethyl-2-phenyloxazoles and their pharmaceutically acceptable acid salts
FR2474863B1 (fr)
IE791178L (en) Dioxolanylmethylazoles

Legal Events

Date Code Title Description
ST Notification of lapse